Abstract: A method for differentiating induced pluripotent stem cells (iPSCs) into retinal ganglion cells (RGCs) involves deleting a sequence encoding LNC000093 long non-coding RNA from the iPSC genome, culturing the modified iPSCs to generate colonies, and dissociating these colonies to form embryoid bodies. The embryoid bodies are transferred to a first plate to induce neural rosette formation. The neural rosettes are detached and cultured in suspension to develop into neurospheres, which are subsequently transferred to a second plate to promote differentiation into RGCs.

Abstract: Provided is a method for preparing a crosslinked polyvinyl chloride structure foamed material by using a physical foaming agent, comprising: melting and mixing a polyvinyl chloride resin, a modified resin, an isocyanate, an anhydride, a nucleating agent and a heat stabilizer to obtain a blank; immersing the blank into a foaming gas for foaming to obtain a foamed body; and subjecting the foamed body to crosslinking curing to obtain a crosslinked polyvinyl chloride structure foamed material. According to the present invention, the crosslinked polyvinyl chloride structure foamed material is prepared by means of a brand-new process route, and the composition and proportion of the PVC resin and other raw materials can be adjusted in a wide range; and carbon dioxide or nitrogen is used for foaming. Further provided is a crosslinked polyvinyl chloride structure foamed material.

Abstract: Novel membranes suitable for use in separation applications are described, as well as processes by which the membranes are made and uses of the membranes in a range of separation applications. The membranes are obtainable by an interfacial polymerisation reaction involving two monomers, in which at least one of the monomers comprises oligomeric portions that are suitable for tuning the separation characteristics of the membrane, particularly in liquid separations, such as organic solvent nanofiltration.

Abstract: A method for grasping texture-less metal parts based on BOLD image matching comprises: obtaining a real image and CAD template images by photographing, extracting a foreground part of the input part image, calculating a covariance matrix of a foreground image, establishing the direction of a temporary coordinate system, and setting directions of line segments to point to a first or second quadrant of the temporary coordinate system; constructing a descriptor of each line segment according to an angle relation between the line segment and k nearest line segments, and matching the descriptors of different line segments in the real image and the CAD template images to obtain line segment pairs; and recognizing a processed pose through a PNL algorithm to obtain a pose of a real texture-less metal part, and then inputting the pose of the real texture-less metal part to a mechanical arm to grasp the part.

Abstract: A method for grasping texture-less metal parts based on BOLD image matching comprises: obtaining a real image and CAD template images by photographing, extracting a foreground part of the input part image, calculating a covariance matrix of a foreground image, establishing the direction of a temporary coordinate system, and setting directions of line segments to point to a first or second quadrant of the temporary coordinate system; constructing a descriptor of each line segment according to an angle relation between the line segment and k nearest line segments, and matching the descriptors of different line segments in the real image and the CAD template images to obtain line segment pairs; and recognizing a processed pose through a PNL algorithm to obtain a pose of a real texture-less metal part, and then inputting the pose of the real texture-less metal part to a mechanical arm to grasp the part.

Abstract: The present invention relates to a novel naphtho class of compounds as Stat3 pathway inhibitors and as cancer stem cell inhibitors; to methods of using such compounds to treat cancer; to methods of using such compounds to treat disorders in a mammal related to aberrent Stat3 pathway activity; to pharmaceutical compositions containing such compounds.

Abstract: 2-dimensional carbon thin films are described, as well as their processes of preparation, and their specific uses. The 2-dimensional carbon thin films are fabricated by preparing an organic polymeric thin film precursor, which is then subjected to a carbonisation process to remove at least some of the non-carbon atoms. Using the disclosed process, 2-dimensional carbon thin films having improved dimensional characteristics can be reliably prepared, which presents clear advantages in applications which have until now been restricted to the use of 2-dimensional carbon thin films having less useful dimensions.

Abstract: The present invention relates to a novel naphtho class of compounds as Stat3 pathway inhibitors and as cancer stem cell inhibitors; to methods of using such compounds to treat cancer; to methods of using such compounds to treat disorders in a mammal related to aberrent Stat3 pathway activity; to pharmaceutical compositions containing such compounds.

Abstract: 2-dimensional carbon thin films are described, as well as their processes of preparation, and their specific uses. The 2-dimensional carbon thin films are fabricated by preparing an organic polymeric thin film precursor, which is then subjected to a carbonisation process to remove at least some of the non-carbon atoms. Using the disclosed process, 2-dimensional carbon thin films having improved dimensional characteristics can be reliably prepared, which presents clear advantages in applications which have until now been restricted to the use of 2-dimensional carbon thin films having less useful dimensions.

Abstract: The present invention relates to a novel naphtho class of compounds as Stat3 pathway inhibitors and as cancer stem cell inhibitors; to methods of using such compounds to treat cancer; to methods of using such compounds to treat disorders in a mammal related to aberrent Stat3 pathway activity; to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to a novel naphtho class of compounds as Stat3 pathway inhibitors and as cancer stem cell inhibitors; to methods of using such compounds to treat cancer; to methods of using such compounds to treat disorders in a mammal related to aberrant Stat3 pathway activity; to pharmaceutical compositions containing such compounds.

Abstract: A damping splice sleeve may include an outer cylinder, a damping material, an inner cylinder. The outer cylinder is a hollow cylinder with partition. The partition divides the cylinder into two smaller cylinders. The two smaller cylinders have no connection with each other. Both ends of the outer cylinder are open. The inner cylinder includes two hollow cylinders with one end closed and the other end open. The damping material is installed between inner cylinder and outer cylinder. The damping splice sleeve can be used for the components' connections of precast building structures with vibration control requirements. When the load effects make the components have relative displacement, the damping material in the damping splice sleeve can have shear deformation and then dissipate energy.

Abstract: The present invention discloses esters of 4,9-dihydroxy-naphtho[2,3-b]furans and methods of making and using the same. The present invention also discloses conversion of the esters into therapeutically active 4,9-dihydroxy-naphtho[2,3-b]furans in vivo. The present invention furthermore discloses pharmaceutical compositions comprising the esters of 4,9-dihydroxy-naphtho[2,3-b]furans for the treatment of various indications including proliferative diseases.

Abstract: The present invention relates to a novel naphtho class of compounds as Stat3 pathway inhibitors and as cancer stem cell inhibitors; to methods of using such compounds to treat cancer; to methods of using such compounds to treat disorders in a mammal related to aberrent Stat3 pathway activity; to pharmaceutical compositions containing such compounds.

Abstract: A printed circuit board assembly (PCBA) chip package component includes: a module board and an interface board. A first soldering pad is set on the bottom of the module board, a second soldering pad is set on top of the interface board, and the second soldering pad is of a castle-type structure. The first soldering pad includes a first soldering area, a second soldering area, and a connection bridge that connects the first soldering area and the second soldering area. The first soldering area corresponds to a top surface of the second soldering pad, and when the first soldering area is soldered to second soldering pad, the second soldering area is located outside the second soldering pad.

Abstract: The present invention relates to a novel naphtho class of compounds as Stat3 pathway inhibitors and as cancer stem cell inhibitors; to methods of using such compounds to treat cancer; to methods of using such compounds to treat disorders in a mammal related to aberrant Stat3 pathway activity; to pharmaceutical compositions containing such compounds.

Abstract: The present invention discloses novel naphtho[2,3-b]furan-4,9-diones and naphtho[2,3-b]thiophene-4,9-diones and methods of making and using the same. The present invention also discloses pharmaceutical compositions comprising novel naphtho[2,3-b]furan-4,9-dione or naphtho[2,3-b]thiophene-4,9-diones for the treatment of various indications including proliferative diseases.

Abstract: The present invention discloses esters of 4,9-dihydroxy-naphtho[2,3-b]furans and methods of making and using the same. The present invention also discloses conversion of the esters into therapeutically active 4,9-dihydroxy-naphtho[2,3-b]furans in vivo. The present invention furthermore discloses pharmaceutical compositions comprising the esters of 4,9-dihydroxy-naphtho[2,3-b]furans for the treatment of various indications including proliferative diseases.

Abstract: The present invention discloses novel naphtho[2,3-b]furan-4,9-diones and naphtho[2,3-b]thiophene-4,9-diones and methods of making and using the same. The present invention also discloses pharmaceutical compositions comprising novel naphtho[2,3-b]furan-4,9-dione or naphtho[2,3-b]thiophene-4,9-diones for the treatment of various indications including proliferative diseases.